← FDA DRUG APPROVALS

FDA ANDA · ANDA076918

FLUCONAZOLE

Sponsor: TARO PHARM INDS

APPLICATION
ANDA076918
TYPE
ANDA
ORIGINAL APPROVAL
2006-12-18
LATEST ACTION
2015-08-27
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

FLUCONAZOLEDiscontinued
FLUCONAZOLE 200MG/5ML · FOR SUSPENSION · ORAL
FLUCONAZOLEDiscontinued
FLUCONAZOLE 50MG/5ML · FOR SUSPENSION · ORAL

Approval history

2015-08-27Labeling · Supplement 6 · standardAP
2015-08-27Labeling · Supplement 4 · standardAP
2015-08-27Labeling · Supplement 5 · standardAP
2012-04-18Labeling · Supplement 3AP
2012-01-25Labeling · Supplement 2AP
2008-11-06Labeling · Supplement 1AP
2006-12-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →